MILD COGNITIVE IMPAIRMENT: AGING TO ALZHEIMER’S DISEASE

By Snowden J. S.  

Brain, Vol. 127, Iss. 1, 2004-01 ,pp. : 231-233

Oxford University Press

Access to resources Recommend Favorite

Platelet phospholipase A₂ activity in Alzheimer’s disease and mild cognitive impairment

By Gattaz W. F.   Forlenza O. V.   Talib L. L.   Barbosa N. R.   Bottino C. M. C.  

Journal of Neural Transmission, Vol. 111, Iss. 5, 2004-05 ,pp. : 591-601

Springer Publishing Company

Access to resources Recommend Favorite

Comparing regional brain atrophy in mild cognitive impairment and Alzheimer’s disease

By Weiler Marina   Cendes Fernando   Balthazar Marcio LF  

Neurodegenerative Disease Management, Vol. 3, Iss. 5, 2013-10 ,pp. : 417-426

Future Medicine

Access to resources Recommend Favorite

Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

By Hu William   Chen-Plotkin Alice   Arnold Steven   Grossman Murray   Clark Christopher   Shaw Leslie   Pickering Eve   Kuhn Max   Chen Yu   McCluskey Leo   Elman Lauren   Karlawish Jason   Hurtig Howard   Siderowf Andrew   Lee Virginia   Soares Holly   Trojanowski John  

Acta Neuropathologica, Vol. 119, Iss. 6, 2010-06 ,pp. : 669-678

Springer Publishing Company

Access to resources Recommend Favorite

Mitochondrial genotype and risk for Alzheimer’s disease: cross-sectional data from the Vienna-Transdanube-Aging “VITA” study

By Mostafaie N.   Rossmanith W.   Hombauer H.   Dechat T.   Raffelsberger T.   Bauer K.   Worofka B.   Kittl E.   Hofmann J.   Hejtman M.   Kirchmeyr W.   Schreiber W.   Weissgram S.   Jungwirth S.   Fischer P.   Bittner R.   Huber K.  

Journal of Neural Transmission, Vol. 111, Iss. 9, 2004-09 ,pp. : 1155-1165

Springer Publishing Company

Access to resources Recommend Favorite